HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
ketazolam (Marcen)
structure
Also Known As:
Marcen
; MI 49001; Sedotime; Solatran; U 28,774; Unakalm; 11-chloro-8,12b-dihydro-2,8-dimethyl-12b-phenyl-4H-(1,3)oxazino(3,2-d)(1,4)benzodiazepine-4,7(6H)-dione
Networked:
5
relevant articles (
2
outcomes,
2
trials/studies)
Relationship Network
Bio-Agent Context: Research Results
Heterocyclic Compounds: 198
Fused-Ring Heterocyclic Compounds
2-Ring Heterocyclic Compounds
Benzazepines: 5
Benzodiazepines: 8452
ketazolam: 5
Experts
1.
García-Pinillos, Felipe
: 1 article (01/2021)
2.
Latorre-Román, Pedro A
: 1 article (01/2021)
3.
Marco-Contreras, Luis A
: 1 article (01/2021)
4.
Marcén-Cinca, Noel
: 1 article (01/2021)
5.
Roche-Seruendo, Luis E
: 1 article (01/2021)
Related Diseases
1.
Multiple Sclerosis
11/01/1984 - "
Ketazolam is a relatively safe and clinically effective antispasticity agent (especially for patients with multiple sclerosis).
"
08/01/1986 - "
This double-blind cross-over study of 14 severely spastic inpatients with chronic multiple sclerosis reveals that once-daily doses of ketazolam, a new drug, are effective in reducing spasticity in a significant proportion of patients without significant side-effects.
"
2.
Muscle Spasticity (Spastic)
08/01/1986 - "
This double-blind cross-over study of 14 severely spastic inpatients with chronic multiple sclerosis reveals that once-daily doses of ketazolam, a new drug, are effective in reducing spasticity in a significant proportion of patients without significant side-effects.
"
3.
Anxiety Disorders (Anxiety Disorder)
01/01/1988 - "
In a multicenter, double-blind trial, 63 elderly patients who had experienced a generalized anxiety disorder for at least one month were randomly assigned to receive 15 mg of ketazolam (n = 31) or placebo (n = 32) daily for 15 days.
"
01/01/1988 - "
A multicenter, double-blind, between-patient trial comparing two doses of ketazolam (15 and 30 mg) with placebo, each given once daily, in the evening, to 92 outpatients affected by generalized anxiety disorders for at least 1 month, was carried out.
"
4.
Cryopyrin-Associated Periodic Syndromes
01/01/2021 - "
García-Pinillos, F, Roche-Seruendo, LE, Marcen-Cinca, N, Marco-Contreras, LA, and Latorre-Román, PA.
"